Loading
A Tokyo company that sells N-NOSE, a urine test using the sense of smell of tiny worms to flag cancer risk.
Hirotsu Bio Science, headquartered in Chiyoda-ku, Tokyo, and established in August 2016 (company press release, February 2024), sells N-NOSE directly to the public in Japan. The company states the test is not a diagnosis of cancer and does not identify a cancer type.
A Japanese urine test that uses the sense of smell of tiny worms; it is sold directly to the public in Japan, does not say which cancer, and in a real-world analysis about 2 in 100 people with a positive result were found to have cancer (about 12 in 100 after allowing for cancers the follow-up scan can miss).
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/